181 related articles for article (PubMed ID: 34185554)
1. Impact of financial medication assistance on medication adherence: a systematic review.
Hung A; Blalock DV; Miller J; McDermott J; Wessler H; Oakes MM; Reed SD; Bosworth HB; Zullig LL
J Manag Care Spec Pharm; 2021 Jul; 27(7):924-935. PubMed ID: 34185554
[No Abstract] [Full Text] [Related]
2. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.
Fendrick AM; Brixner D; Rubin DT; Mease P; Liu H; Davis M; Mittal M
J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252
[No Abstract] [Full Text] [Related]
3. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
Brixner D; Rubin DT; Mease P; Mittal M; Liu H; Davis M; Ganguli A; Fendrick AM
J Manag Care Spec Pharm; 2019 Jul; 25(7):770-779. PubMed ID: 31081461
[TBL] [Abstract][Full Text] [Related]
4. Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression.
Mardan J; Hussain MA; Allan M; Grech LB
J Manag Care Spec Pharm; 2021 Sep; 27(9):1273-1295. PubMed ID: 34464209
[No Abstract] [Full Text] [Related]
5. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
6. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. The Role of Patient Financial Assistance Programs in Reducing Costs for Cancer Patients.
Zullig LL; Wolf S; Vlastelica L; Shankaran V; Zafar SY
J Manag Care Spec Pharm; 2017 Apr; 23(4):407-411. PubMed ID: 28345445
[TBL] [Abstract][Full Text] [Related]
9. Using Previous Medication Adherence to Predict Future Adherence.
Kumamaru H; Lee MP; Choudhry NK; Dong YH; Krumme AA; Khan N; Brill G; Kohsaka S; Miyata H; Schneeweiss S; Gagne JJ
J Manag Care Spec Pharm; 2018 Nov; 24(11):1146-1155. PubMed ID: 30362915
[TBL] [Abstract][Full Text] [Related]
10. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
Holt RIG; Gossage-Worrall R; Hind D; Bradburn MJ; McCrone P; Morris T; Edwardson C; Barnard K; Carey ME; Davies MJ; Dickens CM; Doherty Y; Etherington A; French P; Gaughran F; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Saxon D; Shiers D; Siddiqi N; Swaby EA; Waller G; Wright S
Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
[TBL] [Abstract][Full Text] [Related]
11. Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study.
Krumme AA; Franklin JM; Isaman DL; Matlin OS; Tong AY; Spettell CM; Brennan TA; Shrank WH; Choudhry NK
J Manag Care Spec Pharm; 2017 Apr; 23(4):494-502. PubMed ID: 28345442
[TBL] [Abstract][Full Text] [Related]
12. Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.
Ke X; Kavati A; Wertz D; Huang Q; Wang L; Willey VJ; Stephenson JJ; Ortiz B; Paknis B; Bernstein JA; Beck LA
J Manag Care Spec Pharm; 2018 Jul; 24(7):598-606. PubMed ID: 29952712
[TBL] [Abstract][Full Text] [Related]
13. Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.
Hung A; Mullins CD; Slejko JF; Haines ST; Shaya F; Lugo A
J Manag Care Spec Pharm; 2019 Mar; 25(3):342-349. PubMed ID: 30816818
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
[No Abstract] [Full Text] [Related]
15. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Anstrom KJ; Fonarow GC; Henry TD; Cannon CP; Choudhry NK; Cohen DJ; Atreja N; Bhalla N; Eudicone JM; Wang TY
Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006182. PubMed ID: 32393129
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs.
Doll JA; Kaltenbach LA; Anstrom KJ; Cannon CP; Henry TD; Fonarow GC; Choudhry NK; Fonseca E; Bhalla N; Eudicone JM; Peterson ED; Wang TY
J Am Heart Assoc; 2020 Apr; 9(8):e014975. PubMed ID: 32299284
[TBL] [Abstract][Full Text] [Related]
17. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE
Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526
[TBL] [Abstract][Full Text] [Related]
18. Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review.
Fusco N; Sils B; Graff JS; Kistler K; Ruiz K
J Manag Care Spec Pharm; 2023 Jan; 29(1):4-16. PubMed ID: 35389285
[No Abstract] [Full Text] [Related]
19. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
Brouwer E; Yeung K; Barthold D; Hansen R
J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
[No Abstract] [Full Text] [Related]
20. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
